Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · USD
$25.1
-0.80 (-3.1%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first DYN analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 4.7B | |
|---|---|---|
| Net income (ttm) | -451.7M | |
| EPS (ttm) | -$3.18 | |
| Shares out | 186.6M | |
| Volume | 2,105,170 | |
| Beta | 1.06 | |
| Price target | $39.3 | +56.7% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -451.7M
- EPS (ttm)
- -$3.18
- Market cap
- 4.7B
Fair-value bridge
- Current price
- $25.1
Analyst consensus
Recommendation
Strong Buy
Price target
$39.3
+56.7%
In the news
Latest news · DYN
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 4.7B
- P/B
- 4.8x
Profitability
- ROE
- -58.9%
- ROA
- -32.7%
- ROIC
- -34.1%
Balance sheet
- Debt / equity
- 0.19
- Current ratio
- 19.92
- Quick ratio
- 18.97
Trading
- Beta
- 1.06
- Volume
- 2,105,170
- Dividend yield
- 0.0%